All lanes : Anti-RanGAP1 antibody [1B4] (ab119092) at 1/1000 dilutionLane 1 : HEK293T cell lysate transfected with pCMV6-ENTRY control cDNALane 2 : HEK293T cell lysate transfected with pCMV6-ENTRY RanGAP1 cDNALysates/proteins at 5 µg per lane.developed using the ECL technique
All lanes : Anti-RanGAP1 antibody [1B4] (ab119092) at 1/1000 dilutionLane 1 : HepG2 cell extractLane 2 : HeLa cell extractLane 3 : HT29 cell extractLane 4 : A549 cell extractLane 5 : COS7 cell extractLane 6 : Jurkat cell extractLane 7 : MDCK cell extractLane 8 : PC12 cell extractLane 9 : MCF7 cell extractLysates/proteins at 35 µg per lane.developed using the ECL technique
ab119092 at 1/50 dilution staining RanGAP1 in paraffin-embedded Human Liver tissue by Immunohistochemistry.
ab119092 at 1/50 dilution staining RanGAP1 in paraffin-embedded Human ovary adenocarcinoma tissue by Immunohistochemistry.
ab119092 at 1/50 dilution staining RanGAP1 in paraffin-embedded Human Prostate tissue by Immunohistochemistry.
ab119092 at 1/100 dilution staining RanGAP1 in COS7 cells transiently transfected with pCMV6-ENTRY RanGAP1, by Immunofluorescence.
ab119092 at 1/100 dilution staining RanGAP1 in HEK293T cells transfected with either pCMV6-ENTRY RanGAP1 overexpress plasmid (Red) or empty vector control plasmid (Blue) and analysed by Flow Cytometry.
ab119092 at 1/100 dilution staining RanGAP1 in HeLa cells by Flow cytometry (Red) compared to a nonspecific negative control antibody (Blue).
ab119092 at 1/100 dilution staining RanGAP1 in Jurkat cells by Flow cytometry (Red) compared to a nonspecific negative control antibody (Blue).